RESUMEN
The osteotropic interleukin-6 (IL-6) types of cytokines IL-6, IL-11, and leukemia inhibitory factor (LIF), but not oncostatin M, are expressed by human gingival fibroblasts, and their expressions are regulated by IL-1 and tumor necrosis factor-alpha (TNF-alpha). In the present study, we investigated whether signaling through Toll-like receptor 2 (TLR2) can affect the expression of these cytokines in human gingival fibroblasts. Lipopolysac-charide (LPS) from P. gingivalis was found to stimulate IL-6 and LIF mRNA and protein, but not IL-11 or OSM mRNA. Using two synthetic ligands acting specifically at TLR2 and siRNA knockdown of TLR2, we demonstrated the important role of TLR2 in the stimulation of IL-6 and LIF in gingival fibroblasts. Analysis of these data suggests that signaling through the innate immune system controls the expression of osteotropic cytokines in human gingival fibroblasts.
Asunto(s)
Resorción Ósea/fisiopatología , Encía/metabolismo , Interleucina-6/biosíntesis , Factor Inhibidor de Leucemia/biosíntesis , Receptor Toll-Like 2/fisiología , Análisis de Varianza , Células Cultivadas , Fibroblastos/metabolismo , Técnicas de Silenciamiento del Gen , Encía/citología , Humanos , Interleucina-11/biosíntesis , Lipopolisacáridos/farmacología , Porphyromonas gingivalis/química , ARN Mensajero/biosíntesis , ARN Interferente Pequeño/metabolismo , Estadísticas no Paramétricas , Receptor Toll-Like 2/agonistas , Receptor Toll-Like 4/fisiologíaRESUMEN
Propolis has been used as a medicinal agent to treat infections and promote wound healing for centuries. The aim of the present study was to test the antimicrobial, antioxidant, and cytotoxic activities of a new type of Brazilian propolis, popularly called red propolis, as well as to analyze its chemical composition. The antimicrobial activity against Staphylococcus aureus ATCC 25923 and Staphylococcus mutans UA159 was evaluated and the chloroform fraction (Chlo-fr) was the most active with lower MIC ranging from 25 to 50 microg/ml. The hexane fraction (H-fr), having the highest concentration of total flavonoids, showed the best sequestrating activity for the free radical DPPH. The ethanolic extract of propolis (EEP) showed cytotoxic activity for the HeLa tumor cells with an IC(50) of 7.45 microg/ml. When the EEP was analyzed by GC-MS, seven new compounds were found, among which four were isoflavones. Our results showed that the red propolis has biologically active compounds that had never been reported in other types of Brazilian propolis.
Asunto(s)
Medicina Tradicional , Própolis/química , Própolis/farmacología , Abietanos/química , Abietanos/aislamiento & purificación , Animales , Antiinfecciosos/química , Antiinfecciosos/farmacología , Antioxidantes/química , Antioxidantes/aislamiento & purificación , Antioxidantes/farmacología , Benzofuranos/química , Benzofuranos/aislamiento & purificación , Benzopiranos/química , Benzopiranos/aislamiento & purificación , Brasil , Supervivencia Celular/efectos de los fármacos , Cloroformo/química , Cromatografía Líquida de Alta Presión , Cresoles/química , Cresoles/aislamiento & purificación , Equol , Etanol/química , Cromatografía de Gases y Espectrometría de Masas , Células HeLa , Hexanos/química , Humanos , Isoflavonas/química , Isoflavonas/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Pterocarpanos/química , Pterocarpanos/aislamiento & purificación , Quercetina/química , Quercetina/aislamiento & purificación , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Streptococcus mutans/efectos de los fármacos , Streptococcus mutans/crecimiento & desarrolloRESUMEN
Bradykinin related peptides (BRPs) present in the water-soluble secretion and freshly dissected skin fragments of Phyllomedusa hypochondrialis were investigated by mass spectrometry techniques. Eighteen BRPs, along with their post-translational modifications, were characterized in the secretion by de novo MS/MS sequencing and direct MALDI imaging experiments of the frog skin. These molecules revealed strong sequence similarities to the main plasma kinin of some mammals and reptiles. Such a diversity of molecules, within the same peptide family, belonging to a single amphibian species may be related to functional specializations of these peptides and a variety of corresponding receptors that might be present in a number of different predators. Also, a novel analog, [Val]1,[Thr]6-bradykinyl-Gln,Ser had its biological activity positively detected in cell culture expressing the human bradykinin B2 receptor and in guinea pig ileum preparations.
Asunto(s)
Bradiquinina/análogos & derivados , Bradiquinina/química , Ranidae/metabolismo , Secuencia de Aminoácidos , Animales , Células CHO , Cricetinae , Cricetulus , Femenino , Cobayas , Humanos , Hidroxiprolina/química , Espectrometría de Masas , Datos de Secuencia Molecular , Músculo Liso/citología , Músculo Liso/metabolismo , Ranidae/clasificación , Receptor de Bradiquinina B2/química , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , TransfecciónRESUMEN
1. The role of different residues of the rat AT(1A) receptor in the interaction with the N- and C-terminal ends of angiotensin II (AngII) was studied by determining ligand binding and production of inositol phosphates (IP) in COS-7 cells transiently expressing the following AT(1A) mutants: T88H, Y92H, G196I, G196W and D278E. 2. G196W and G196I retained significant binding and IP-production properties, indicating that bulky substituents in position 196 did not affect the interaction of AngII's C-terminal carboxyl with Lys(199) located three residues below. 3. Although the T88A mutation did not affect binding, the T88H mutant had greatly decreased affinity for AngII, suggesting that substitution of Thr(88) by His might hinder binding through an indirect effect. 4. The Y92H mutation caused loss of affinity for AngII that was much less pronounced than that reported for Y92A, indicating that His in that position can fulfil part of the requirements for binding. 5. Replacing Asp(278) by Glu caused a much smaller reduction in affinity than replacing it by Ala, indicating the importance of Asp's beta-carboxyl group for AngII binding. 6. Mutations in residues Thr(88), Tyr(92) and Asp(278) greatly reduced affinity for AngII but not for Sar(1) Leu(8)-AngII, suggesting unfavourable interactions between these residues and AngII's aspartic acid side-chain or N-terminal amino group, which might account for the proposed role of the N-terminal amino group of AngII in the agonist-induced desensitization (tachyphylaxis) of smooth muscles.
Asunto(s)
Angiotensina II/metabolismo , Receptores de Angiotensina/metabolismo , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Angiotensina II/química , Angiotensina II/farmacología , Animales , Unión Competitiva/efectos de los fármacos , Células COS , Relación Dosis-Respuesta a Droga , Fosfatos de Inositol/metabolismo , Radioisótopos de Yodo , Datos de Secuencia Molecular , Mutagénesis , Mutación , Unión Proteica/efectos de los fármacos , Ensayo de Unión Radioligante , Ratas , Receptor de Angiotensina Tipo 1 , Receptores de Angiotensina/genéticaRESUMEN
Xylella fastidiosa is a fastidious, xylem-limited bacterium that causes a range of economically important plant diseases. Here we report the complete genome sequence of X. fastidiosa clone 9a5c, which causes citrus variegated chlorosis--a serious disease of orange trees. The genome comprises a 52.7% GC-rich 2,679,305-base-pair (bp) circular chromosome and two plasmids of 51,158 bp and 1,285 bp. We can assign putative functions to 47% of the 2,904 predicted coding regions. Efficient metabolic functions are predicted, with sugars as the principal energy and carbon source, supporting existence in the nutrient-poor xylem sap. The mechanisms associated with pathogenicity and virulence involve toxins, antibiotics and ion sequestration systems, as well as bacterium-bacterium and bacterium-host interactions mediated by a range of proteins. Orthologues of some of these proteins have only been identified in animal and human pathogens; their presence in X. fastidiosa indicates that the molecular basis for bacterial pathogenicity is both conserved and independent of host. At least 83 genes are bacteriophage-derived and include virulence-associated genes from other bacteria, providing direct evidence of phage-mediated horizontal gene transfer.
Asunto(s)
Genoma Bacteriano , Plantas/microbiología , Pseudomonadaceae/genética , Análisis de Secuencia de ADN , Adhesión Bacteriana , Proteínas Bacterianas/metabolismo , Transporte Biológico , Mapeo Cromosómico , Citrus/microbiología , Reparación del ADN , ADN Bacteriano , Metabolismo Energético , Datos de Secuencia Molecular , Plantas Tóxicas , Biosíntesis de Proteínas , Pseudomonadaceae/metabolismo , Pseudomonadaceae/patogenicidad , Nicotiana/microbiología , Transcripción Genética , Virulencia/genéticaRESUMEN
Two nonpeptide ligands that differ chemically by only a single methyl group but have agonistic (L-162,782) and antagonistic (L-162,389) properties in vivo were characterized on the cloned angiotensin AT1 receptor. Both compounds bound with high affinity (K(I) = 8 and 28 nM, respectively) to the AT1 receptor expressed transiently in COS-7 cells as determined in radioligand competition assays. L-162,782 acted as a powerful partial agonist, stimulating phosphatidylinositol turnover with a bell-shaped dose-response curve to 64% of the maximal level reached in response to angiotensin II. Surprisingly, L-162,389 also stimulated phosphatidylinositol turnover, albeit only to a small percentage of the angiotensin response. The prototype nonpeptide AT1 agonist L-162,313 gave a response of approximately 50%. The apparent EC50 values for all three compounds in stimulating phosphatidylinositol turnover were similar, approximately 30 nM, corresponding to their binding affinity. Each of the three compounds also acted as angiotensin antagonists, yet in this capacity the compounds differed markedly, with IC50 values ranging from 1.05 x 10(-7) M for L-162,389 to 6.5 x 10(-6) for L-162,782. A series of point mutations in the transmembrane segments (TMs) of the AT1 receptor had only minor effect on the binding affinity of the nonpeptide compounds, with the exception of A104V at the top of TM III, which selectively impaired the binding of L-162,782 and L-162,389. Substitutions in the middle of TM III, VI, or VII, which did not affect the binding affinity of the compounds, impaired or eliminated the agonistic efficacy of the nonpeptides but with only minor or no effect on the angiotensin potency or efficacy. Thus, in the N295D rat AT1 construct, L-162,782, L-162,313, and L-162,389 all antagonized the angiotensin-induced phosphatidylinositol turnover with surprisingly similar IC50 values (90-180 nM), and they all bound with unaltered, high affinity (22-36 nM). However, L-162,313 and L-162,782 could stimulate phosphatidylinositol turnover to only 20% of that of angiotensin. It is concluded that minor chemical modifications of either the compound or the receptor can dramatically alter the agonistic efficacy of biphenyl imidazole compounds on the AT1 receptor without affecting their affinity, as determined in binding assays, and that a number of substitutions in the middle of the TM segments affect the efficacy of nonpeptide agonists as opposed to angiotensin.